Clinical Group

International Journal of Immunotherapy and Cancer Research

ISSN: 2455-8591

DOI

CC By

About International Journal of Immunotherapy and Cancer Research

Journal Information
  • Volume/IssueClick here
  • Review ProcessDouble Blind
  • Publication lead time3 - 4 weeks
  • Indexing statusYes; Purview
  • Manuscript Processing ChargesClick here
  • Submission ChargesNo
  • Waiver policy for APCYes
  • Language of Full TextEnglish
  • Full-text formats availablePDF, HTML
Best Practices
  • Type of LicenseCreative Commons
  • Open AccessYes; Policy
  • Does the author retain unrestricted copyright?Yes
  • Does the author retain publishing rights?Yes
  • Permanent article identifierDOI (Digital Object Identifier)

Description

International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving health

Read more

Editorial Board

J Ignacio Tello
Assistant Professor
Department of Applied Mathematics
Technical University of Madrid
Spain
IJICR

Research Interest: Mathematical Modeling of Cancer, differential equations, mathematical oncology, mathematical modeling of Immunotherapy.

Biography
Bo Jin
Professor
Department of Gastroenterology
Peoples Liberation Army
China
IJICR

Research Interest: His interests in liver fibrosis research focuses on the use of intrahepatic administration of collagenase for reversal of liver fibrosis and this work was one of the earliest that established proof-of-principle of these potential therapeutic agents. His immunological interest lies with double-stranded RNA induced immune response and its potential application in anti-virus and/or anti-cancer immunotherapy.

Biography
Karabi Datta
Associate Professor
Chittaranjan National Cancer Institute
India
IJICR

Research Interest: I.Cancer prevention programes i.e Cancer Awareness camps &Early detection of cancer. 2.Epidemiological studies on Breast cancer &Cervical cancer

Biography
D Sugapriya
Assistant Professor
Department of Medical Lab Sciences
Prince Sattam Bin Abdullaziz University
Saudi Arabia
IJICR

Research Interest: Immunophenotyping, Immunocytochemistry, Multilineag differentiation, RNA isolation, RT- PCR, Cancer cell line, Immunocytochemistry, Real-Time PCR, Western blot, Transport mechanism by liquid santillation Counter, Induction of leukemia in experimental animal, Biochemical enzymatic analysis, TEM analysis, Histopathology, RT-PCR, apoptosis analysis, Western blot, MTT assay, Measurement of intracellular ROS, Analysis of mitochondrial membrane potential, Intracellular calcium levels, Quantification of endogenous GSH, DNA fragmentation, Column Chromatography, Antibiotic sensitivity assay, Extract preparation, Antibiotic sensitivity assay

Biography
Khor Goot Heah
Faculty of Dentistry
Universiti Teknologi Mara
Malaysia
IJICR

Research Interest: Oral Sciences, Oral Pathology, Molecular Biology, Cancer Biology, Histochemistry


Biography
Emmanuel Enoch Kwaku
Professor
School of Life Sciences
University of Science and Technology of China
China
IJICR

Research Interest: RNA interefence, Immunotherapy and Immunodiagnostics

Biography
Christiane M Nday
Researcher
Department of Chemistry
University of Cape Town
South Africa
IJICR

Research Interest: Brain cancer immunotherapy, Molecular Bio-Chemistry Neuroscience

Biography
Monica Rinaldi
Research Scientist
Department of BioMedicine
National Research Council
Italy
IJICR

Research Interest: Development of new DNA vaccines and adjuvants for anticancer therapy and/or prevention, intended for clinical application. Preclinical protocols of genetic immunization against tumor-associated antigens Combined therapeutic protocols (vaccination+immunotherapy+chemotherapy) in preclinical research.

Biography
Constantinos Giaginis
Assistant Professor
Department of Food Science & Nutrition
University of Aegean
Greece
IJICR

Research Interest: Research areas of human physiology and pathophysiology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of toxicology and pharmacology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility and ionization of drugs, natural bioactive compounds and toxic chemicals in relation with their potential biological activity and toxicity endpoints, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profiles

Biography
Ji-Liang Li
Professor
Cancer Immunology
Plymouth University
UK
IJICR

Research Interest: Tumour Microenvironment and Translational Cancer Medicine

 Combination of cancer target therapy and immunotherapy

 Tumour associated macrophages

 Notch signalling in cancer biology

 Tumour resistance to target therapy and immunotherapy

 Hypoxia and angiogenesis pathways in cancer biology

 MicroRNAs in cancer target therapy and immunotherapy

 Experimental mouse tumour models

Biography
Karin Schroten-Loef
Integraal Kankercentrum Nederland
Netherlands
IJICR

 Research interests: Carcinoma Unknown Primary Cancer of Unknown Primary (CUP) is the term applied to metastatic cancer of which the origin remains unidentified. Since treatment is usually based on the profile of the primary cancer, treatment of these patients is a challenge. Reports on incidence, treatment, and survival are limited. My personal challenge is to increase the awareness with regard to CUP via research and support patients suffering from CUP, as well as the patients' family and friends. Prostate cancer. Prostate cancer is a disease of elderly males. An increase in prostate cancer is expected in the coming years due to a growing population of men aged over 60 years of age from 475 million in 2009 to 1.6 billion in the year 2050 worldwide. Moreover, if screening for prostate cancer is taken into account, even more men will be diagnosed with this disease. Immunotherapy, especially the role of Interleukin 7 and TGFbeta

Biography
Manoj Kumar
Department of Clinical Microbiology and Immunology
National Institute of Nutrition, ICMR Jamai Osmania
India
IJICR

Research Interest: Gut microbiology; Metabolic diseases; Mucosal Immunology; Cancer; Functional foods and Nutraceutical

Biography
Rasika Rohatgi
Researcher
USA
IJICR

Research Interest: Molecular mechanisms  and  signaling  pathways  underlying  cancer  progressi on,  metastasis and chem resistance

Biography
Hamiyet Donmez-Altuntas
Professor
Department of Medical Biology
Erciyes University
Turkey
IJICR

Research Interest: Molecular biology, cytogenetics, genotoxicity, micronucleus, cytome assay, mutagenicity tests, gene expression, human cancer, pituitary adenomas, obesity.

Biography
Mohammad Zeeshan Najm
Associate Professor
Department of Biochemistry
Hamdard University
India
IJICR

Research Interest: Molecular Biology/Cancer Biology

Biography
View more

Immunomodulatory Effects of Food Additives

Published On: April 17, 2017 | Pages: 019 - 031

Author(s): Hamid Y Dar, Shivani Chaturvedi, Karishma Srivastava, Zaffar Azam, Rajaneesh Anupam, Rajesh K Mondal, Geetanjali B Tomar, Ashish K Singh, Pradyumna K Mishra and Rupesh K Srivastava*
View Article DOI: 10.17352/2455-8591.000015

A Study of Glucosylceramide Synthase and Glycolytic Pathway Enzymes in Patients with Hypereosinophilia

Published On: March 31, 2017 | Pages: 015 - 018

Author(s): Lisa Redmond, Paul Kennedy, Colm Buckley and Philip T Murphy*
View Article DOI: 10.17352/2455-8591.000014

A Very Rare Case of Polycythemia Vera Patient Who Developed Other Four Cancers

Published On: February 03, 2017 | Pages: 012 - 014

Author(s): Romeo-Gabriel Mihaila*
View Article DOI: 10.17352/2455-8591.000013

Immunosuppressive and Cytotoxic Potential of Flavonoids from Medicinal Plants: Preliminary Investigation for Anticancer Activity

Published On: February 01, 2017 | Pages: 007 - 011

Author(s): Amit Gupta* and Revati N Chavan
View Article DOI: 10.17352/2455-8591.000012

Dalton’s Lymphoma as a Murine Model for Understanding the Progression and Development of T-Cell Lymphoma and Its Role in Drug Discovery

Published On: February 01, 2017 | Pages: 001 - 006

Author(s): Raj Kumar Koiri*, Aditi Mehrotra and Surendra Kumar Trigun
View Article DOI: 10.17352/2455-8591.000011

Significance of Cancer Stem Cells in Anti-Cancer Therapies

Published On: December 31, 2016 | Pages: 014 - 016

Author(s): Mónica Botelho* and Helena Alves
View Article DOI: 10.17352/2455-8591.000010

A Synchronous Presentation of AITL with Adenocarcinoma of Lung

Published On: October 06, 2016 | Pages: 011 - 013

Author(s): Kanagaraja Karunakaran Parathan*
View Article DOI: 10.17352/2455-8591.000009

Cytokine Production and Human Cytomegalovirus Load in Allogeneic Hematopoietic Stem Cell Transplantation Outcome

Published On: June 17, 2016 | Pages: 003 - 010

Author(s): TA Silva**, JF Correia-Silva, RG Resende, MHNG Abreu, AL Teixeira, H Bittencourt, RS Gomez
View Article DOI: 10.17352/2455-8591.000008

Endothelial Progenitor Cells in Breast Cancer

Published On: January 23, 2016 | Pages: 001 - 002

Author(s): Monica C Botelho*, Helena Alves
View Article DOI: 10.17352/2455-8591.000007

Anti-VEGF Therapy Induces Proteinuria through Endothelial Disorganization Leading to Nephrin Decrease in Podocytes

Published On: October 28, 2015 | Pages: 021 - 028

Author(s): Marianne Terrasse*, Florence Jouan, Thibault Dolley-Hitze, Yannick Arlot-Bonnemains, Marc-Antoine Belaud-Rotureau, Nathalie Rioux-Leclercq, Nolwenn Lorcy, Cécile Vigneau
View Article DOI: 10.17352/2455-8591.000006
TOP